Cardiovascular Risk Evaluation and Antiretrovirals in HIV

King's College London1,024 enrolled

Overview

The purpose of the study is to determine the main factors contributing to predicted 10 year cardiovascular risk in an HIV infected cohort, and the role of anti-HIV drug use in altering this risk

Study Type

OBSERVATIONAL

Enrollment

1,024

Conditions

Cardiovascular Risk HIV Infections

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Serologically proven HIV infection * Attending general HIV outpatient clinic Exclusion Criteria: * Attending a specialist outpatient clinic which might lead to recruitment bias

Locations (1)

Guys & ST Thomas' Foundation Hospitals

London, United Kingdom

Outcomes

Primary Outcomes

10 year predicted cardiovascular risk

Time frame: AT time of clinic attendence

Secondary Outcomes

coronary heart disease risk

Time frame: at time of clinic attendence

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.